Add to ORKGEmily performed research on potential drugs for the treatment of a type of breast cancer that is especially resistant to chemotherapy
Cancer is the second leading cause of death in the world and it is estimated that 600,000 people wil...
Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancers. It is a heterogeneou...
Cancer is the second leading cause of death in the world and it is estimated that 600,000 people wil...
Triple negative breast cancer (TNBC) is the most aggressive and metastatic type of breast cancer, ac...
Triple negative breast cancer (TNBC) is the most aggressive and metastatic type of breast cancer, ac...
(1) Triple-negative breast cancer (TNBC) is a severe clinical challenge in need of new therapies, bu...
Triple-negative breast cancers (TNBC) are characterized by the lack of or reduced expression of the ...
Triple negative breast cancer (TNBC) is associated with a poor prognosis compared to other types of ...
Triple-negative breast cancer (TNBC) is a pathological term used to identify invasive breast cancers...
Triple-negative breast cancer (TNBC) constitutes a small subtype (~15%) of breast cancer, but causes...
Breast cancer is the most common malignancy in women globally, in which triple-negative breast cance...
Breast cancer is a multifaceted disease that affects 1 in every 8 women. Triple negative breast canc...
Triple negative breast cancer (TNBC) is a highly aggressive type of breast cancer that accounts for ...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
Background: Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive phenotype of breast ...
Cancer is the second leading cause of death in the world and it is estimated that 600,000 people wil...
Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancers. It is a heterogeneou...
Cancer is the second leading cause of death in the world and it is estimated that 600,000 people wil...
Triple negative breast cancer (TNBC) is the most aggressive and metastatic type of breast cancer, ac...
Triple negative breast cancer (TNBC) is the most aggressive and metastatic type of breast cancer, ac...
(1) Triple-negative breast cancer (TNBC) is a severe clinical challenge in need of new therapies, bu...
Triple-negative breast cancers (TNBC) are characterized by the lack of or reduced expression of the ...
Triple negative breast cancer (TNBC) is associated with a poor prognosis compared to other types of ...
Triple-negative breast cancer (TNBC) is a pathological term used to identify invasive breast cancers...
Triple-negative breast cancer (TNBC) constitutes a small subtype (~15%) of breast cancer, but causes...
Breast cancer is the most common malignancy in women globally, in which triple-negative breast cance...
Breast cancer is a multifaceted disease that affects 1 in every 8 women. Triple negative breast canc...
Triple negative breast cancer (TNBC) is a highly aggressive type of breast cancer that accounts for ...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
Background: Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive phenotype of breast ...
Cancer is the second leading cause of death in the world and it is estimated that 600,000 people wil...
Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancers. It is a heterogeneou...
Cancer is the second leading cause of death in the world and it is estimated that 600,000 people wil...